In Vitro Fertilization Market By Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), By Type (Conventional IVF, IVF with ICSI), By End User (Fertility Clinics, Hospitals, Cryobanks) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

In Vitro Fertilization Market accounted for US$ 628 million in 2020 and is estimated to be US$ 1468.9 million by 2030 and is anticipated to register a CAGR of 9.0%.

In Vitro Fertilization (IVF) is a type of assisted reproductive technology (ART) that involves extracting eggs from a woman's ovaries and fertilizing them with sperm in a laboratory setting. The procedure entails activating a woman's ovulatory system, extracting an ovum from her ovaries, and fertilizing the ovum with sperm in a laboratory liquid. IVF is one of the most commonly used procedures to help couples with infertility concerns, which is a major element driving the worldwide IVF services market. The global in vitro fertilization services market is expected to develop significantly throughout the projected period, owing to an increase in the rate of infertility, an increase in the trend of delayed pregnancies, a jump in IVF success rates, and an increase in disposable income globally. The worldwide stoppage of in vivo fertilisation therapy was precipitated by the COVID-19 pandemic, which had a significant impact on women having IVF operations. Every year, 30 lakh people in India seek IVF treatment. However, IVF/intrauterine insemination (IUI) operations are performed on only 5 lakh patients. COVID-19 is a conference that takes place every two years. During the epidemic, the number of persons performing IVF cycles dropped by 90%. COVID-19's spread has had an influence on fertility clinics, resulting in the cancellation of IVF treatments, as well as fertility decisions among couples who had chosen IVF treatment before to the pandemic.

Growth in male infertility boost the market growth

People nowadays are more focused on their careers than on family planning, and as a result, late pregnancies are common. As previously said, the rising incidence of such situations is a major in vivo fertiliser market driver, as complex cases are frequently treated through IVF treatmeInt. This is more widespread in countries like the United Kingdom, Japan, and the United States. Aside from that, the growth in male infertility is expected to enhance IVF treatment adoption and, as a result, accelerate the in vivo fertilisation market size in the next years. Aside from that, government-backed reimbursement regulations and public awareness campaigns are assisting the region's overall in vivo fertilisation industry growth.

However, the high cost and problems associated with IVF therapy, as well as low awareness of IVF in underdeveloped regions, are impeding the market's expansion. In contrast, an increase in fertility tourism, an increase in the number of reproductive clinics, and lower IVF costs in developing nations compared to industrialised ones are predicted to provide lucrative market expansion potential.

In Vitro Fertilization Market is segmented based on product, type, end-user and region.

On the basis of Product, the In Vitro Fertilization Market is segmented into Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories. Based on Type, the target market is segmented into Conventional IVF, IVF with ICSI. Based on End-User, the target market is segmented into Fertility Clinics, Hospitals, Cryobanks.

Regional Insights:

On region the In Vitro Fertilization Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Because of the increased prevalence of related disorders such as polycystic ovarian syndrome, the in vivo fertilisation market in North America is predicted to develop significantly (PCOS). The study market in the region is expected to be driven by a continual rise in the frequency of infertility in both sexes. According to the SingleCare online survey, 20 percent of respondents got in vivo fertilisation (IVF) in the United States in October 2020. In addition, 19% of respondents said they had polycystic ovarian syndrome (PCOS), and 25% said they were infertile for unknown reasons. As a result, the market's expansion is being fueled by the increased incidence of infertility. The demand for infertility treatment equipment in the region is being driven by factors such as newly opened fertility centres and reimbursement policies for infertility treatment. For example, as of August 2020, 19 states had approved fertility insurance coverage legislation, 13 of which included IVF coverage, and 10 states had passed fertility preservation laws for iatrogenic (medically-induced) infertility. As a result, the rate of treatment will rise, increasing demand for fertility treatment equipment. In addition, in September 2020, Inception Fertility (Inception) established Pathways Fertility (Pathways), a new network of clinics in Atlanta and Georgia, with the goal of changing the fertility market's paradigm and improving the patient experience. This could increase the treatment rate among the infertile population, positively impacting the area economy.

In Vitro Fertilization Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the In Vivo Fertilization Market report based on Product, Type, End-User and region.

In Vivo Fertilization Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The prominent players operating in the In Vitro Fertilization Market include The Cooper Companies Inc. (US), Cook Group (US), Vivolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Limited (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Corning Corporation (US), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), FERTIPRO NV(Belgium), and Eppendorf (Germany).

• The Cooper Companies Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cook Group
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Vivolife
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Esco Micro Pte. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Genea Limited
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Eppendorf
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Hamilton Thorne Ltd.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies